2025-12-28 - Analysis Report
Here's a comprehensive analysis of Northrop Grumman Corp (NOC) based on the provided data.

**0) Summary Numbers & Comparison to S&P 500 (VOO)**

*   **NOC Cumulative Return:** 49.81%
*   **VOO Cumulative Return:** 103.21%
*   **Divergence:** -53.4% (Current), Range: -59.4% (Min) to 56.8% (Max)
*   **Relative Divergence:** 5.2% (Near the bottom of its historical divergence range)

**1) Analysis of NOC's Performance vs. S&P 500 (VOO)**

*   **Company Overview:** Northrop Grumman Corp. is a leading global aerospace and defense technology company.
*   **Performance:** NOC has significantly underperformed the S&P 500 (VOO) over the period analyzed. The cumulative return is far lower.
*   **Divergence Analysis:** The divergence of -53.4% indicates a large gap between NOC's returns and the market's. A relative divergence of 5.2% shows that this underperformance is near the worst it has been historically within the observed period.

**Alpha, Beta Analysis:**

| Year       | CAGR  | MDD   | Alpha  | Beta | Cap(B) |
|------------|-------|-------|--------|------|--------|
| 2015-2017  | 46.0% | 65.6% | 17.0%  | 0.0  | 43.9   |
| 2016-2018  | -2.0% | 74.3% | -17.0% | 0.0  | 35.1   |
| 2017-2019  | 17.0% | 79.2% | -5.0%  | 0.9  | 49.2   |
| 2018-2020  | -28.0% | 79.9% | -52.0% | 0.8  | 43.6   |
| 2019-2021  | 43.0% | 79.9% | -4.0%  | 0.8  | 55.4   |
| 2020-2022  | 18.0% | 79.9% | 19.0%  | 0.3  | 78.1   |
| 2021-2023  | 24.0% | 82.7% | 23.0%  | 0.2  | 67.0   |
| 2022-2024  | -15.0% | 82.7% | -36.0% | 0.2  | 67.2   |
| 2023-2025  | -1.0% | 82.1% | -68.0% | 0.1  | 82.7   |

*   **CAGR:** The Compound Annual Growth Rate fluctuates significantly, showing inconsistent performance over different periods. Recent years show negative or near-zero growth.
*   **MDD:** Maximum Drawdown is consistently high, indicating significant potential for losses.
*   **Alpha:** Alpha is often negative, meaning NOC has underperformed relative to its benchmark (risk-adjusted basis). The most recent period shows a particularly large negative alpha (-68.0%).
*   **Beta:** Beta has decreased and remains low, ranging between 0.1 and 0.3 in recent years. This suggests that NOC's price movement is less correlated with the overall market.
*   **Market Cap:** The company's market capitalization has generally increased over the period.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** $577.37
*   **Previous Close:** $582.35
*   **Change:** -$0.86 (-0.86%)
*   **5-day SMA:** $578.58
*   **20-day SMA:** $563.55
*   **60-day SMA:** $580.01

The price is currently below both the 5-day and 60-day SMAs, suggesting potential short-term downward momentum. The 20-day SMA is below the current price, but the overall picture suggests consolidation or a slight downward trend.

**3) Indicators Analysis**

*   **Market Risk Indicator (MRI):** 1.0 (High Investment Recommended). *This should be interpreted with caution given the other negative indicators.*
*   **RSI:** 66.52 (Approaching overbought territory, suggesting the stock may be due for a pullback).
*   **PPO:** 0.55 (Positive, but relatively small, indicating a slightly positive price momentum relative to its moving averages).
*   **Hybrid Signal:** "cash_0%_Buy 100% of cash (4 shares - Very Safe - MRI:0.90) Dividend_2.31 Monthly invest 0.8% of total investment ($1,000.00)"  This signal is contradictory given the other indicators. While the MRI is high, the underperformance and other factors should be considered.
*   **Recent Relative Divergence Change:** -0.5 (Indicates short-term decline relative to its comparison benchmark)
*   **Expected Return:** -151.2% (Significantly negative, indicating a very pessimistic outlook compared to S&P 500 if invested long-term.)
*   **Price Change:** The recent price change of -0.86 suggests a moderate fluctuation.

**4) Recent News & Significant Events**

*   **Mixed Sentiment:** The news articles present a mixed picture.
    *   **Negative:** One article discusses a rating downgrade ("Northrop Grumman: An Argument For Buying At Undervaluation"). Another mentions Voya Investment Management selling NOC shares.
    *   **Positive/Neutral:** One article suggests a potential upside of 19% ("Analysts See a 19% Upside to Northrop Grumman Corporation"). Another considers whether it's too late to invest after a strong 2025 rally. One article discusses the investment outlook (December 7, 2025).
    *   **Technical Analysis:** One article discusses potential gains based on a chart ("Northrop Grumman Signal 25/12: More Gains Ahead?").

**4-2) Analyst Opinions**

*   **Consensus:** Analysts generally rate NOC as a "Buy" (Mean = 2.04).
*   **Target Price:** The average target price is $662.68, suggesting a potential upside from the current price.
*   **Recent Rating Changes:** No specific changes are provided in the data.

**5) Recent Earnings Analysis**

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-10-21 | 7.69  | 10.42 B$  |
| 2025-07-22 | 8.17  | 10.35 B$  |
| 2025-04-22 | 3.33  | 9.47 B$   |
| 2024-10-24 | 7.02  | 10.00 B$  |
| 2025-10-21 | 7.02  | 10.00 B$  |

*   **EPS:** Earnings Per Share (EPS) has fluctuated. The most recent figure of 7.69 is reasonably healthy.
*   **Revenue:** Revenue has been relatively stable, around $10 billion per quarter. The figure of 9.47 B$ in 2025-04-22 is a bit lower.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue     | Profit Margin |
|--------------|-------------|---------------|
| 2025-09-30   | $10.42B     | 21.37%        |
| 2025-06-30   | $10.35B     | 21.35%        |
| 2025-03-31   | $9.47B      | 16.69%        |
| 2024-12-31   | $10.69B     | 18.08%        |
| 2024-09-30   | $10.00B     | 21.07%        |

*   **Revenue:** Revenue is relatively consistent, with a slight dip in the March 2025 quarter.
*   **Profit Margin:** Profit margins are generally strong, but experienced a noticeable decrease in the March 2025 quarter.

**Capital and Profitability:**

| Quarter      | Equity     | ROE   |
|--------------|------------|-------|
| 2025-09-30   | $15.99B    | 6.88% |
| 2025-06-30   | $15.47B    | 7.59% |
| 2025-03-31   | $14.98B    | 3.21% |
| 2024-12-31   | $15.29B    | 8.27% |
| 2024-09-30   | $14.75B    | 6.96% |

*   **Equity:** Equity has generally increased over the past few quarters.
*   **ROE:** Return on Equity (ROE) has been fluctuating. There was a significant decrease in Q1 2025, while it has slightly recovered but remains lower compared to the end of 2024.

**7) Comprehensive Analysis**

Northrop Grumman (NOC) has underperformed the S&P 500 significantly. While analyst consensus is a "Buy" and target prices suggest potential upside, several factors raise concerns.

*   **Underperformance:** NOC has lagged the market substantially. Its low relative divergence compared to VOO indicates that the underperformance has been historically bad.
*   **Mixed Signals:** While the Market Risk Indicator (MRI) is high, this conflicts with a significantly negative expected return and negative Alpha values. The high MRI should not be considered in isolation.
*   **Recent Decline:** Recent moving average analysis and relative divergence suggest a short-term downward trend.
*   **Profitability Concerns:** While revenue is consistent, a dip in profit margin in Q1 2025 and fluctuating ROE raise questions about recent profitability trends.
*   **News Sentiment:** The news articles present a mixed picture, with both positive and negative viewpoints.

**Conclusion:**

Based on the available data, a cautious approach to investing in NOC is warranted. The analyst consensus and target prices offer some optimism, but the underperformance relative to the S&P 500, the negative Alpha, the mixed signals from technical indicators, and concerns around recent profitability trends should be carefully considered. Further research into the reasons for NOC's underperformance is advisable before making an investment decision. The very negative expected return compared to the S&P 500 serves as a significant red flag.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.